key: cord-0308014-w6td8sdw authors: Jang, Kyung Ku; Kaczmarek, Maria E; Dallari, Simone; Chen, Ying-Han; Axelrad, Jordan; Stapleford, Kenneth A; Cadwell, Ken title: Intestinal organoids expose heterogeneity in SARS-CoV-2 susceptibility date: 2021-07-16 journal: bioRxiv DOI: 10.1101/2021.07.16.452680 sha: 0c13f7cc12cba8192606ec56cc95848515dc2af5 doc_id: 308014 cord_uid: w6td8sdw Organoids generated from primary human specimens facilitate investigation of the intestinal barrier by recreating the complex cellular composition of the epithelium. Although the significance remains unclear, intestinal organoid lines display heterogeneity in their growth and morphology. We hypothesized that organoids will also display variability in the degree to which they are susceptible to infectious agents. Using SARS-CoV-2 as a model, we found orders of magnitude differences in the amount of SARS-CoV-2 recovered from small intestinal and colonic organoids generated from different donors. SARS-CoV-2 burden did not correlate with demographic or clinical features associated with donors, but rather reflected the expression level of the virus receptor ACE2. Remarkably, organoid ACE2 transcript levels matched the amount of ACE2 detected in primary tissue from the same individual, indicating that certain properties of the intestinal epithelium are retained during ex vivo differentiation. Longitudinal transcriptomics of organoids identified a delayed yet robust interferon signature, the magnitude of which corresponded to the degree of SARS-CoV-2 infection. These results suggest that intestinal organoids display substantial heterogeneity in their ability to support viral infections and can potentially inform mechanisms behind interindividual differences in susceptibility to infectious disease. To determine the degree to which ACE2, TMPRSS2, and TMRPSS4 were differentially 81 expressed between donors and culture conditions, we established and differentiated 3D organoid 82 lines from small intestinal and colonic biopsies procured from 8 and 10 donors, respectively 83 (Supplemental Table 1 ). Consistent with previous observations (32, 33) , the expression of ACE2, 84 TMPRSS2, and the enterocyte marker of differentiation APOA1 were significantly higher in small 85 intestinal and colonic organoid lines cultured in 3D differentiation media (3DD) compared with 86 those cultured in expansion media (3DE) that maintains organoids in an undifferentiated state 87 (Supplemental Fig. 1A, B and D) . TMRPSS4 expression was similar in both conditions 88 (Supplemental Fig. 1C ). Donor-to-donor variability in expression was apparent for all four genes. Intestinal organoids can be grown as differentiated monolayers to expose the apical side and 90 facilitate viral entry. We found that the level of ACE2, TMPRSS2, TMPRSS4, and APOA1 91 expression in monolayer organoids correlated well with 3DD organoids generated from the same 92 donor (Fig. 1A) , suggesting that organoid lines retain their intrinsic gene expression patterns 93 independent of these two culturing conditions. In addition, we found that monolayer organoids 94 exhibited the highest ACE2 and TMPRSS2 expression among the culture conditions we examined 95 ( Fig. 1B and C) . Therefore, we used the monolayer model to perform all subsequent analyses. Finally, we investigated whether ACE2, TMPRSS2, or TMPRSS4 expression differed between 97 small intestinal and colonic biopsy monolayers. Although ACE2 expression did not differ between 98 organoids derived from the small intestine versus colon, TMPRSS2 and TMRPSS4 expression 99 were higher and APOA1 was decreased in colonic organoids ( Fig. 1F -I). The lack of correlation 100 between ACE2 or TMPRSS2 expression and APOA1 expression suggested that heterogeneous 101 ACE2 and TMPRSS2 levels were not an artifact caused by insufficient differentiation 102 (Supplemental Fig. 2A and B). Given that organoids were derived from healthy donors and patients with inflammatory 104 bowel disease (IBD) of both sexes, we examined whether these donor attributes contribute to 105 differences in gene expression patterns. When we segregated the data based on disease status 106 or sex in either small intestinal or colonic organoids, we did not observe significant differences in The association between susceptibility of organoids to SARS-CoV-2 infection and ACE2 127 expression was clear in most cases, but there were outliers for the colonic organoids. For instance, C5 and C8 have moderate to high levels of ACE2 but low levels of virus production ( Fig. 2A and 129 B). Thus, we investigated whether other factors may contribute to differential SARS-CoV-2 130 infectivity. Several polymorphisms are predicted to alter the stability of ACE2 or alter its affinity to 131 the SARS-CoV-2 S protein (43-46). However, the sequence of the ACE2 coding region of C5 and 132 C8 were identical to other donors (Supplemental Table 1 ). Differences in interferon responses 133 may also contribute to SARS-CoV-2 infectivity, where higher ISG levels are predicted to confer 134 protections against viral infection (47-49). Baseline ISG15, OASL, and MX2 expression did not 135 correlate with lower virus production. Instead, we noticed a positive correlation between OASL 136 and SARS-CoV-2 susceptibility (Supplemental Fig. 3F -H). Next, we examined ISG expression 137 following stimulation with interferon-beta (IFNβ) or interferon-lambda 2 (IFNλ2). Although we 138 observed varied levels of ISG induction, they were not associated with reduced viral infection 139 (Supplemental Fig. 4A ; Supplemental Table 3 ). Generally, we did not detect an association 140 between the degree to which these ISGs were induced and properties of the donor tissue location, 141 disease status, and age (Supplemental Fig. 4A to C and Supplemental Our results thus far are consistent with the possibility that ACE2 gene expression is a key 147 determinant of the degree to which the intestinal epithelium of an individual is susceptible to SARS-CoV-2 infection. As organoids are differentiated from primary stem cells and expanded in 149 culture (50, 51), it was unclear whether inter-donor differences reflect ACE2 levels in the primary 150 tissues. Therefore, we measured ACE2 protein by immunofluorescence microscopy in small 151 intestinal and colonic sections from the same donors corresponding to individual lines of 152 organoids (Fig. 3) . ACE2 staining was restricted to the epithelium and most intense along the 153 apical brush boarder (villi in the small intestine and top of the crypts in the colon; Fig. 3A To further investigate how susceptible and resistant organoids differ from each other, we 162 selected the three colonic organoid lines that each displayed high infection (HI; C1, C2, and C7) 163 or low infection (LI; C8, C9, and C10) for RNA-seq analysis. We validated the transcriptional and 164 microscopy analyses ( Fig. 2A , C, and D) by Western blot, which showed higher levels of ACE2 165 protein in HI compared with LI organoids, and comparable levels of TMPRSS2 protein (Fig. 4A ). We then infected the organoids with SARS-CoV-2 for 24 and 72 hrs (I24 and I72, respectively), 167 and compared these samples with mock infected organoids harvested at 0 and 72 hrs (UI0 and 168 UI72, respectively). Because these six organoid lines were prepared from independently thawed 169 batches of frozen stocks, we quantified virus and confirmed that higher amounts of SARS-CoV-2 170 were recovered from HI compared with LI organoids at both time points (Fig. 4B and C) . Similar infection already diverged between resistant and susceptible organoids. Therefore, these gene expression patterns are unlikely to account for differential susceptibility, and instead, provide a 217 glimpse as to how increased viral replication can affect properties of the intestinal epithelium. Although the presence of SARS-CoV-2 RNA in the gut has been associated with diarrhea in Finally, it is notable that organoids retained the differential ACE2 levels observed in intact Culture of human small intestinal and colonic organoids: Human organoids were cultured as described previously (7, 58 Immunofluorescence: ACE2 staining were performed as described previously (68) Immunoblotting: Organoids were processed for immunoblotting as previously described (66) Plus Gels (Invitrogen), transferred onto PVDF membranes, and blocked using 5% skim milk. The following antibodies were used for immunoblotting studies: mouse anti-β-actin (1:5,000, Sigma, AC-15), rabbit anti-ACE2 (1:1,000, Abcam, ab15348), mouse anti-TMPRSS2 (1:1,000, Santa Cruz, sc-515727). Secondary antibodies (mouse anti-rabbit and goat-anti mouse, 211- Sequencing was performed on Illumina NovaSeq 6000 (Illumina). RNA-seq results were 360 processed using the R package "DESeq2" to obtain variance stabilized count reads, fold 361 changes relative to specific condition, and statistical P-value. Analysis of the organoid 362 transcriptome focused on differentially expressed genes, defined as the genes with an absolute 363 fold change relative to specific condition >2 and an adjusted P-value <0.05. Computational and statistical analysis 366 Gene ontology analysis was performed using the R package "clusterProfiler". Principal Component Analysis was performed using the R package "stats". Heatmaps were generated 368 using the R package "pheatmap". Upstream regulators analysis was performed by uploading 369 the differentially expressed genes to Ingenuity Pathway Analysis software (Qiagen). Statistical differences were determined as described in figure legend using either R or 371 GraphPad Prism 9 software (La Jolla, CA, USA). Data availability The accession number for the gene expression raw data reported in this paper is GSE179949. Bars represent mean ± SEM, and at least 2 independent experiments were performed. *P ≤ 0.05, 483 and **P ≤ 0.01, by unpaired t test, two-tailed in B and C. Somatic cell-derived organoids as prototypes of human epithelial tissues 582 and diseases 584 Salmonella enterica Serovar Typhimurium Exploits Cycling through Epithelial Cells To 585 Colonize Human and Murine Enteroids. mBio Stem cell-587 derived human intestinal organoids as an infection model for rotaviruses Norovirus 590 Replication in Human Intestinal Epithelial Cells Is Restricted by the Interferon-Induced 591 Signaling Pathway and RNA Polymerase II-Mediated Transcriptional Responses. 592 mBio Somatic 595 inflammatory gene mutations in human ulcerative colitis epithelium An 598 intestinal organoid-based platform that recreates susceptibility to T-cell-mediated tissue injury. 599 Blood Automated brightfield 601 morphometry of 3D organoid populations by Coronaviruses and 603 gastrointestinal diseases Digestive system manifestations and clinical 605 significance of coronavirus disease 2019: A systematic literature review Diarrhea During COVID-19 608 Infection: Pathogenesis, Epidemiology, Prevention, and Management Extrapulmonary manifestations of COVID-19 Prevalence and Characteristics of Gastrointestinal Symptoms in Patients With Severe Acute 614 Respiratory Syndrome Coronavirus 2 Infection in the United States: A Multicenter Cohort Study Gastrointestinal 617 Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong 618 Cohort: Systematic Review and Meta-analysis Gastrointestinal Symptoms and Coronavirus Disease 2019: A Case-Control Study From the 621 United States Digestive System Involvement and Clinical Outcomes in a Large Academic Hospital in Milan Evolution 626 of antibody immunity to SARS-CoV-2 Incidence and Persistence of Viral Shedding in COVID-19 Post-acute Patients With Negativized 629 Pharyngeal Swab: A Systematic Review CoV-2 in Fecal Samples From Patients With Asymptomatic and Mild COVID-19 in Korea. Clin 632 Gastroenterol Hepatol Virological assessment of hospitalized patients with COVID-2019 First Case of 637 2019 Novel Coronavirus in the United States Coronavirus Disease 2019 in China Evidence for Gastrointestinal Infection 641 of SARS-CoV-2 A 643 method for detection of SARS-CoV-2 RNA in healthy human stool: a validation study 646 Gastrointestinal involvement attenuates COVID-19 severity and mortality Faecal 648 calprotectin indicates intestinal inflammation in COVID-19 CoV-2-specific IgA and limited inflammatory cytokines are present in the stool of select patients 651 with acute COVID-19. medRxiv Infectious SARS-CoV-2 in Feces of 653 Patient with Severe COVID-19 Histopathology 655 and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and 659 Is Detected in Specific Cell Subsets across Tissues Single-661 cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics 664 TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal 665 enterocytes SARS-CoV-2 productively infects human gut enterocytes Infection of bat and human 669 intestinal organoids by SARS-CoV-2 Critical 671 Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial 672 Cells SARS-CoV-2 receptor 674 ACE2 gene expression in small intestine correlates with age The Role of Angiotensin Converting Enzyme 2 in 677 Modulating Gut Microbiota, Intestinal Inflammation, and Coronavirus Infection Altered Intestinal 680 ACE2 Levels Are Associated With Inflammation, Severe Disease, and Response to Anti-681 Intestinal 683 Inflammation Modulates the Expression of ACE2 and TMPRSS2 and Potentially Overlaps With 684 the Pathogenesis of SARS-CoV-2-related Disease Single-cell 686 analyses reveal SARS-CoV-2 interference with intrinsic immune response in the human gut Specific ACE2 expression in 689 small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV 690 infection Reduced expression 692 of COVID-19 host receptor, ACE2 is associated with small bowel inflammation, more severe 693 disease, and response to anti-TNF therapy in Crohn's disease. medRxiv SARS-CoV-2 infection susceptibility influenced by ACE2 genetic polymorphisms: 696 insights from Tehran Cardio-Metabolic Genetic Study Investigation of the genetic variation in ACE2 on 698 the structural recognition by the novel coronavirus (SARS-CoV-2) Molecular docking 701 simulation reveals ACE2 polymorphisms that may increase the affinity of Khayat AS, de Assumpcao PP ACE2 polymorphisms as potential players in COVID-19 705 outcome Antiviral 707 Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts 708 SARS-CoV-2. mBio Magnitude and timing of the antiviral response determine SARS-CoV-2 replication early in 711 infection. medRxiv Innate immune and inflammatory responses to SARS-713 CoV-2: Implications for COVID-19 Long-term 715 expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's 716 epithelium Adult stem cells in the small intestine are intrinsically programmed with 719 their location-specific function Activation and evasion of type I 721 interferon responses by SARS-CoV-2 Type-I 723 interferon signatures in SARS-CoV-2 infected Huh7 cells Influenza virus 725 infection induces metallothionein gene expression in the mouse liver and lung by overlapping 726 but distinct molecular mechanisms Metallothionein is induced and 728 trace element balance changed in target organs of a common viral infection TLR-7 activation 731 enhances IL-22-mediated colonization resistance against vancomycin-resistant enterococcus An enteric virus can replace the beneficial function of 734 commensal bacteria IFN-I and IL-22 mediate protective effects of intestinal viral infection Selective Interferon Responses of 739 Intestinal Epithelial Cells Minimize Tumor Necrosis Factor Alpha Cytotoxicity Interferons Link Viral Infection to Enhanced Epithelial Turnover and Repair ATG16L1 745 orchestrates interleukin-22 signaling in the intestinal epithelium via cGAS-STING Commensal viruses maintain 748 intestinal intraepithelial lymphocytes via noncanonical RIG-I signaling IFN-lambda suppresses intestinal inflammation 751 by non-translational regulation of neutrophil function Enteric Viruses Ameliorate 753 Gut Inflammation via Toll-like Receptor 3 and Toll-like Receptor 7-Mediated Interferon-beta 754 Production Autophagy 756 proteins suppress protective type I interferon signalling in response to the murine gut microbiota Autophagy protein ATG16L1 prevents necroptosis in the intestinal epithelium An Infectious 762 cDNA Clone of SARS-CoV-2 ACE2 localizes to the 764 respiratory cilia and is not increased by ACE inhibitors or ARBs